These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9020620)

  • 1. Improving the cost-to-benefit ratio of in-vitro fertilization.
    Silva PD; Sorensen ML; Silva DE
    Wis Med J; 1997 Jan; 96(1):36-9. PubMed ID: 9020620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamete intrafallopian transfer. A cost-effective alternative to donor oocyte in vitro fertilization in women aged 40-42 years.
    Silva PD; Olson KL; Meisch JK; Silva DE
    J Reprod Med; 1998 Dec; 43(12):1019-22. PubMed ID: 9883404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-saving treatment strategies in in vitro fertilization: a combined economic evaluation of two large randomized clinical trials comparing highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone alpha.
    Wechowski J; Connolly M; Schneider D; McEwan P; Kennedy R
    Fertil Steril; 2009 Apr; 91(4):1067-76. PubMed ID: 18339384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A detailed cost analysis of in vitro fertilization and intracytoplasmic sperm injection treatment.
    Bouwmans CA; Lintsen BM; Eijkemans MJ; Habbema JD; Braat DD; Hakkaart L
    Fertil Steril; 2008 Feb; 89(2):331-41. PubMed ID: 17662286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of assisted reproductive technologies for a health maintenance organization.
    Hidlebaugh DA; Thompson IE; Berger MJ
    J Reprod Med; 1997 Sep; 42(9):570-4. PubMed ID: 9336753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic implications of insurance coverage for in vitro fertilization in the United States. A review.
    Omurtag KR; Styer AK; Session D; Toth TL
    J Reprod Med; 2009; 54(11-12):661-8. PubMed ID: 20120898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost analysis of shared oocyte in vitro fertilization.
    Peskin BD; Austin C; Lisbona H; Goldfarb JM
    Obstet Gynecol; 1996 Sep; 88(3):428-30. PubMed ID: 8752253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partnership for Families Program: philanthropy for in vitro fertilization patients.
    Goldfarb JM; Fisher NL; Gillespie L; Austin CM; Lisbona H; Peskin BD; Desai N
    J Reprod Med; 2009 Sep; 54(9):548-52. PubMed ID: 19947031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural in vitro fertilization cycles.
    Ubaldi F; Rienzi L; Ferrero S; Baroni E; Iacobelli M; Sapienza F; Minasi MG; Cobellis L; Romano S; Scarselli F; Greco E
    Ann N Y Acad Sci; 2004 Dec; 1034():245-51. PubMed ID: 15731316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effects of oocyte cryopreservation in assisted reproduction technology].
    Wang W; Yan ZJ; Cai LB; Chai DC; Liu CZ; Mao YD; Liu JY
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(39):2755-8. PubMed ID: 19080449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single embryo transfer and IVF/ICSI outcome: a balanced appraisal.
    Gerris JM
    Hum Reprod Update; 2005; 11(2):105-21. PubMed ID: 15514015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of in vitro fertilization.
    Stern Z; Laufer N; Levy R; Ben-Shushan D; Mor-Yosef S
    Isr J Med Sci; 1995 Aug; 31(8):492-6. PubMed ID: 7635699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro fertilization (IVF) versus gonadotropins followed by IVF as treatment for primary infertility: a cost-based decision analysis.
    Kansal-Kalra S; Milad MP; Grobman WA
    Fertil Steril; 2005 Sep; 84(3):600-4. PubMed ID: 16169391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiency of oocyte cryopreservation: a meta-analysis.
    Oktay K; Cil AP; Bang H
    Fertil Steril; 2006 Jul; 86(1):70-80. PubMed ID: 16818031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of singleton versus twin pregnancies after in vitro fertilization.
    Lukassen HG; Schönbeck Y; Adang EM; Braat DD; Zielhuis GA; Kremer JA
    Fertil Steril; 2004 May; 81(5):1240-6. PubMed ID: 15136084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human oocyte cryopreservation: a valid alternative to embryo cryopreservation?
    Tucker M; Morton P; Liebermann J
    Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113 Suppl 1():S24-7. PubMed ID: 15041126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint.
    Polinder S; Heijnen EM; Macklon NS; Habbema JD; Fauser BJ; Eijkemans MJ
    Hum Reprod; 2008 Feb; 23(2):316-23. PubMed ID: 18033807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
    Santiago-Delefosse M; Cahen F; Coeffin-Driol C
    Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost].
    de Mouzon J; Allavena E; Schmitt C; Frappé M
    Gynecol Obstet Fertil; 2004 Jun; 32(6):508-18. PubMed ID: 15217566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model.
    Fiddelers AA; Dirksen CD; Dumoulin JC; van Montfoort AP; Land JA; Janssen JM; Evers JL; Severens JL
    Hum Reprod; 2009 Jul; 24(7):1648-55. PubMed ID: 19318703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.